S&P 500   3,946.53 (+0.24%)
DOW   32,053.41 (+0.07%)
QQQ   310.39 (+1.39%)
AAPL   159.43 (+1.01%)
MSFT   278.35 (+2.23%)
META   204.82 (+2.51%)
GOOGL   105.51 (+2.07%)
AMZN   99.07 (+0.37%)
TSLA   191.86 (+0.37%)
NVDA   269.76 (+1.92%)
NIO   9.25 (+1.76%)
BABA   86.12 (+2.95%)
AMD   100.32 (+2.81%)
T   18.52 (+0.71%)
F   11.47 (-0.09%)
MU   60.95 (+4.78%)
CGC   1.91 (+1.60%)
GE   91.50 (+2.13%)
DIS   96.32 (+1.50%)
AMC   4.40 (+1.38%)
PFE   40.26 (+0.62%)
PYPL   72.44 (-2.56%)
NFLX   315.84 (+7.47%)
S&P 500   3,946.53 (+0.24%)
DOW   32,053.41 (+0.07%)
QQQ   310.39 (+1.39%)
AAPL   159.43 (+1.01%)
MSFT   278.35 (+2.23%)
META   204.82 (+2.51%)
GOOGL   105.51 (+2.07%)
AMZN   99.07 (+0.37%)
TSLA   191.86 (+0.37%)
NVDA   269.76 (+1.92%)
NIO   9.25 (+1.76%)
BABA   86.12 (+2.95%)
AMD   100.32 (+2.81%)
T   18.52 (+0.71%)
F   11.47 (-0.09%)
MU   60.95 (+4.78%)
CGC   1.91 (+1.60%)
GE   91.50 (+2.13%)
DIS   96.32 (+1.50%)
AMC   4.40 (+1.38%)
PFE   40.26 (+0.62%)
PYPL   72.44 (-2.56%)
NFLX   315.84 (+7.47%)
S&P 500   3,946.53 (+0.24%)
DOW   32,053.41 (+0.07%)
QQQ   310.39 (+1.39%)
AAPL   159.43 (+1.01%)
MSFT   278.35 (+2.23%)
META   204.82 (+2.51%)
GOOGL   105.51 (+2.07%)
AMZN   99.07 (+0.37%)
TSLA   191.86 (+0.37%)
NVDA   269.76 (+1.92%)
NIO   9.25 (+1.76%)
BABA   86.12 (+2.95%)
AMD   100.32 (+2.81%)
T   18.52 (+0.71%)
F   11.47 (-0.09%)
MU   60.95 (+4.78%)
CGC   1.91 (+1.60%)
GE   91.50 (+2.13%)
DIS   96.32 (+1.50%)
AMC   4.40 (+1.38%)
PFE   40.26 (+0.62%)
PYPL   72.44 (-2.56%)
NFLX   315.84 (+7.47%)
S&P 500   3,946.53 (+0.24%)
DOW   32,053.41 (+0.07%)
QQQ   310.39 (+1.39%)
AAPL   159.43 (+1.01%)
MSFT   278.35 (+2.23%)
META   204.82 (+2.51%)
GOOGL   105.51 (+2.07%)
AMZN   99.07 (+0.37%)
TSLA   191.86 (+0.37%)
NVDA   269.76 (+1.92%)
NIO   9.25 (+1.76%)
BABA   86.12 (+2.95%)
AMD   100.32 (+2.81%)
T   18.52 (+0.71%)
F   11.47 (-0.09%)
MU   60.95 (+4.78%)
CGC   1.91 (+1.60%)
GE   91.50 (+2.13%)
DIS   96.32 (+1.50%)
AMC   4.40 (+1.38%)
PFE   40.26 (+0.62%)
PYPL   72.44 (-2.56%)
NFLX   315.84 (+7.47%)
TSE:COM

138267 (COM.TO) - COM Stock Forecast, Price & News

Add
Compare
Today's Range
N/A
50-Day Range
C$2.95
▼
C$2.95
52-Week Range
N/A
Volume
9,197 shs
Average Volume
19,585 shs
Market Capitalization
C$102.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About 138267 (COM.TO)

Cardiome Pharma Corp., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of patients suffering from heart diseases. It offers BRINAVESS (vernakalant (IV)) for the conversion of recent onset atrial fibrillation to sinus rhythm in adults; and AGGRASTAT, a reversible GP IIb/IIIa inhibitor for use in acute coronary syndrome patients. The company also provides ESMOCARD and ESMOCARD LYO short-acting beta-blockers used to control rapid heart rate; XYDALBA, a semi-synthetic lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections; and TREVYENT for the treatment of pulmonary arterial hypertension. It has operations in Canada, the United States, Europe, and internationally. The company was formerly known as Nortran Pharmaceuticals Inc. and changed its name to Cardiome Pharma Corp. in June 2001. Cardiome Pharma Corp. was founded in 1986 and is headquartered in Vancouver, Canada.

Receive COM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 138267 (COM.TO) and its competitors with MarketBeat's FREE daily newsletter.

COM Stock News Headlines

August 18, 2022 | forbes.com
North Carolina Income Tax Calculator 2021
August 16, 2022 | forbes.com
Ohio Income Tax Calculator 2021
March 23, 2023 | Investor Place Media (Ad)
Biden To Unleash "Choke Point" Operation On America?
Biden's disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.
July 5, 2022 | forbes.com
Tennessee Income Tax Calculator 2021
July 5, 2022 | forbes.com
California Income Tax Calculator 2021
February 15, 2022 | forbes.com
Missouri Income Tax Calculator 2021
February 15, 2022 | forbes.com
Kansas Income Tax Calculator 2021
January 21, 2022 | msn.com
8,640 new Covid cases, 13 deaths Friday
March 23, 2023 | Investor Place Media (Ad)
Biden To Unleash "Choke Point" Operation On America?
Biden's disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.
January 5, 2022 | au.finance.yahoo.com
Ophir Asset Management Pty Ltd - Ophir High Conviction Fund (OPH.AX)
August 26, 2020 | marketwatch.com
Acute Coronary Syndrome Therapeutics Market 2020 Top Leading Players, Gross Margin Analysis, Size, Market Share, Trends, Types to 2025
June 17, 2020 | www.bloomberg.com
Cipher Pharmaceuticals Completes Acquisition of Canadian Business Portfolio of Cardiome Pharma
May 15, 2020 | finance.yahoo.com
Correvio Announces Results from Annual General and Special Meeting of Securityholders
May 8, 2020 | finance.yahoo.com
Entheon Biomedical Announces Private Placement to Begin Pre-clinical Trials with Psychedelic Compounds DMT & 5 MEO DMT
May 5, 2020 | www.marketwatch.com
Acute Coronary Syndrome Therapeutics Market: Facts, Figures and Analytical Insights 2020-2026
March 30, 2020 | www.marketwatch.com
Global Acute Coronary Syndrome Therapeutics Market 2020 Industry Analysis, Key Players, Type and Application, Regions, Forecast to 2025
February 18, 2020 | www.theglobeandmail.com
Vancouver clean-tech startup SemiosBio raises $102-million on pest-control product
January 20, 2020 | markets.businessinsider.com
Cipher Pharmaceuticals Receives Notice of Termination from Bausch
December 10, 2019 | finance.yahoo.com
Correvio Pharma In The Spotlight Amid Brinavess Adcom Verdict
November 14, 2019 | seekingalpha.com
Correvio Pharma EPS misses by $0.06, misses on revenue
August 14, 2019 | seekingalpha.com
Correvio Pharma EPS misses by $0.05, misses on revenue
May 8, 2019 | seekingalpha.com
Correvio Pharma misses by $0.03, misses on revenue
March 19, 2019 | seekingalpha.com
Cipher Pharmaceuticals, Inc. (CPHRF) CEO Robert Tessarolo on Q4 2018 Results - Earnings Call Transcript
See More Headlines
Receive COM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 138267 (COM.TO) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
TSE
Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
TSE:COM
CUSIP
N/A
CIK
N/A
Web
www.cardiome.com
Phone
+1-604-6776905
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
34,639,000
Free Float
N/A
Market Cap
C$102.19 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Dr. William L. Hunter (Age 55)
    Pres, CEO & Director
  • Ms. Sheila M. Grant MBA
    Chief Operating Officer
  • Mr. David D. McMasters (Age 59)
    Gen. Counsel
  • Mr. Hugues Sachot
    Chief Commercial Officer
  • Mr. Justin A. Renz (Age 46)
    Chief Financial Officer

Key Competitors

View All Competitors













COM Stock - Frequently Asked Questions

Is 138267 (COM.TO) a good dividend stock?

138267 (COM.TO) (TSE:COM) pays an annual dividend of C$0.02 per share and currently has a dividend yield of 0.00%.

What other stocks do shareholders of 138267 (COM.TO) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other 138267 (COM.TO) investors own include Aurora Cannabis (ACB), Aphria (APHA), Bombardier, Inc. Class B (BBD.B), Cardiome Pharma (CRME), Macy's (M), Meta Growth (NACNF), ProMetic Life Sciences (PLI), Teva Pharmaceutical Industries (TEVA), Hydropothecary (THCX) and AGT Food and Ingredients (AGT).

What is 138267 (COM.TO)'s stock symbol?

138267 (COM.TO) trades on the Toronto Stock Exchange (TSX) under the ticker symbol "COM."

How do I buy shares of 138267 (COM.TO)?

Shares of COM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

How much money does 138267 (COM.TO) make?

138267 (COM.TO) (TSE:COM) has a market capitalization of C$0.00.

How can I contact 138267 (COM.TO)?

138267 (COM.TO)'s mailing address is 1441 Creekside Dr 6th Floor, VANCOUVER, BC V6J 4S7, Canada. The official website for the company is www.cardiome.com. The biopharmaceutical company can be reached via phone at +1-604-6776905.

This page (TSE:COM) was last updated on 3/23/2023 by MarketBeat.com Staff